Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference40 articles.
1. Hepatocellular carcinoma: epidemiology and clinical aspects;Mazzanti;Mol Aspects Med,2008
2. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis;Sherman;Semin Liver Dis,2010
3. A decade's studies on metastasis of hepatocellular carcinoma;Tang;J Cancer Res Clin Oncol,2004
4. Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma;Avielronen;Mod Pathol,2008
5. Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma;Chen;Clin Chim Acta,2013
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. IL-21- and CXCL9-engineered GPC3-specific CAR-T cells combined with PD-1 blockade enhance cytotoxic activities against hepatocellular carcinoma;Clinical and Experimental Medicine;2024-08-28
2. Synthesis and preclinical evaluation of a novel probe [18F]AlF-NOTA-IPB-GPC3P for PET imaging of GPC3 positive tumor;Bioorganic Chemistry;2024-06
3. British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults;Gut;2024-04-16
4. Prognostic Factors after Hepatectomy for Hepatocellular Carcinoma—The Importance of Pathological Immunophenotyping, the Steatohepatitic Subtype and the Impact of the Hepatic Pedicle Clamping;Gastrointestinal Disorders;2024-04-15
5. Engineered exosomes loaded with M1–8 peptide for targeted therapy of hepatocellular carcinoma;Applied Materials Today;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3